Swedish Cancer Institute,1221 Madison St. — Seattle, Washington

Swedish Cancer Institute,1221 Madison St. is a clinical research site located in Seattle, Washington, United States 98104.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Swedish Cancer Institute,1221 Madison St. has participated in 1 clinical trials.

Therapeutic areas: Chronic Lymphocytic Leukemia, Peripheral T-cell Lymphoma.

Sponsors: Aptevo Therapeutics.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Swedish Cancer Institute,1221 Madison St.?

Swedish Cancer Institute,1221 Madison St. has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Swedish Cancer Institute,1221 Madison St. conducted?

Swedish Cancer Institute,1221 Madison St. has 1 clinical trials on record. Their work covers Chronic Lymphocytic Leukemia, Peripheral T-cell Lymphoma.

Is Swedish Cancer Institute,1221 Madison St. accredited by Crixeo Health?

Swedish Cancer Institute,1221 Madison St. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Swedish Cancer Institute,1221 Madison St.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.